Circulating MMP-9 levels are also increased in type 2 diabetes patients with coronary artery disease, and elevated serum MMP-9 concentrations, associated with decreased inhibitor levels (TIMP-1), have been linked to premature coronary atherosclerosis (45–48). The gene discussed is MMP9; the disease is coronary atherosclerosis.